These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 15699494)

  • 21. Exogenous CLIP localizes into endocytic compartment of cells upon internalization: implications for antigen presentation by MHC class II molecules.
    Mukherjee R; Chaturvedi P; Lee-Chan E; Singh B
    Mol Immunol; 2008 Apr; 45(8):2166-76. PubMed ID: 18279957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T cells to a dominant epitope of GAD65 express a public CDR3 motif.
    Quinn A; McInerney M; Huffman D; McInerney B; Mayo S; Haskins K; Sercarz E
    Int Immunol; 2006 Jun; 18(6):967-79. PubMed ID: 16641112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Type 1 diabetes genes and pathways shared by humans and NOD mice.
    Wicker LS; Clark J; Fraser HI; Garner VE; Gonzalez-Munoz A; Healy B; Howlett S; Hunter K; Rainbow D; Rosa RL; Smink LJ; Todd JA; Peterson LB
    J Autoimmun; 2005; 25 Suppl():29-33. PubMed ID: 16257508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glutathione-s-transferase M1 and T1 polymorphisms and associations with type 1 diabetes age-at-onset.
    Bekris LM; Shephard C; Peterson M; Hoehna J; Van Yserloo B; Rutledge E; Farin F; Kavanagh TJ; Lernmark A
    Autoimmunity; 2005 Dec; 38(8):567-75. PubMed ID: 16390810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SlC30A8 is a major target of humoral autoimmunity in type 1 diabetes and a predictive marker in prediabetes.
    Wenzlau JM; Moua O; Sarkar SA; Yu L; Rewers M; Eisenbarth GS; Davidson HW; Hutton JC
    Ann N Y Acad Sci; 2008 Dec; 1150():256-9. PubMed ID: 19120307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T cell immunity to glutamic acid decarboxylase in fulminant type 1 diabetes without significant elevation of serum amylase.
    Aoki K; Taniyama M; Nagayama C; Oikawa Y; Shimada A
    Ann N Y Acad Sci; 2006 Oct; 1079():181-5. PubMed ID: 17130552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Type 1 diabetes: lessons for other autoimmune diseases?
    Harrison LC; Honeyman MC; Morahan G; Wentworth JM; Elkassaby S; Colman PG; Fourlanos S
    J Autoimmun; 2008 Nov; 31(3):306-10. PubMed ID: 18558477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulitis in human type 1 diabetes.
    Hanafusa T; Imagawa A
    Ann N Y Acad Sci; 2008 Dec; 1150():297-9. PubMed ID: 19120316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The association of CTLA-4 and HLA class II autoimmune risk genotype with regulatory T cell marker expression in 5-year-old children.
    Jonson CO; Hedman M; Karlsson Faresjö M; Casas R; Ilonen J; Ludvigsson J; Vaarala O;
    Clin Exp Immunol; 2006 Jul; 145(1):48-55. PubMed ID: 16792673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MHC class I chain-related gene-A is associated with IA2 and IAA but not GAD in Swedish type 1 diabetes mellitus.
    Gupta M; Graham J; McNeeny B; Zarghami M; Landin-Olsson M; Hagopian WA; Palmer J; Lernmark A; Sanjeevi CB
    Ann N Y Acad Sci; 2006 Oct; 1079():229-39. PubMed ID: 17130560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A unique T cell subset described as CD4loCD40+ T cells (TCD40) in human type 1 diabetes.
    Waid DM; Wagner RJ; Putnam A; Vaitaitis GM; Pennock ND; Calverley DC; Gottlieb P; Wagner DH
    Clin Immunol; 2007 Aug; 124(2):138-48. PubMed ID: 17560173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. "Humanized" HLA transgenic NOD mice to identify pancreatic beta cell autoantigens of potential clinical relevance to type 1 diabetes.
    Serreze DV; Marron MP; Dilorenzo TP
    Ann N Y Acad Sci; 2007 Apr; 1103():103-11. PubMed ID: 17376821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential nerve injury-induced expression of MHC class II in the mouse correlates to genetic variability in the type I promoter of C2ta.
    Harnesk K; Swanberg M; Diez M; Olsson T; Piehl F; Lidman O
    J Neuroimmunol; 2009 Jul; 212(1-2):44-52. PubMed ID: 19481818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural analysis of H2-Db class I molecules containing two different allelic forms of the type 1 diabetes susceptibility factor beta-2 microglobulin: implications for the mechanism underlying variations in antigen presentation.
    Roden MM; Brims DR; Fedorov AA; DiLorenzo TP; Almo SC; Nathenson SG
    Mol Immunol; 2006 Mar; 43(9):1370-8. PubMed ID: 16229893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HLA and autoimmune diseases: Type 1 diabetes (T1D) as an example.
    Gorodezky C; Alaez C; Murguía A; Rodríguez A; Balladares S; Vazquez M; Flores H; Robles C
    Autoimmun Rev; 2006 Mar; 5(3):187-94. PubMed ID: 16483918
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GAD65- and proinsulin-specific CD4+ T-cells detected by MHC class II tetramers in peripheral blood of type 1 diabetes patients and at-risk subjects.
    Oling V; Marttila J; Ilonen J; Kwok WW; Nepom G; Knip M; Simell O; Reijonen H
    J Autoimmun; 2005 Nov; 25(3):235-43. PubMed ID: 16263242
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The MHC Class II Antigen-Processing and Presentation Pathway Is Dysregulated in Type 1 Diabetes.
    Gilles A; Hu L; Virdis F; Sant'Angelo DB; Dimitrova N; Hedrick JA; Denzin LK
    J Immunol; 2023 Dec; 211(11):1630-1642. PubMed ID: 37811896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T Cell Receptor Genotype and
    Mordes JP; Cort L; Liu Z; Eberwine R; Blankenhorn EP; Pierce BG
    Genes (Basel); 2021 Jun; 12(6):. PubMed ID: 34205929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MHC and non-MHC gene regulation of disease susceptibility and disease course in experimental inflammatory peripheral neuropathy.
    de Graaf KL; Wallström E; Muhallab S; Wiesmüller KH; Olsson T; Weissert R
    J Neuroimmunol; 2004 Oct; 155(1-2):73-84. PubMed ID: 15342198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Apollinaire Bouchardat Prize 2000. Immunogenetic approach to type 1 diabetes in man].
    Caillat-Zucman S
    Journ Annu Diabetol Hotel Dieu; 2000; ():39-51. PubMed ID: 10932867
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.